Using the CARD system for university-based pop-up vaccination clinics: A two-stage hybrid effectiveness-implementation study.

IF 3.5 4区 医学 Q2 BIOTECHNOLOGY & APPLIED MICROBIOLOGY
Human Vaccines & Immunotherapeutics Pub Date : 2025-12-01 Epub Date: 2025-08-07 DOI:10.1080/21645515.2025.2509484
Victoria Gudzak, Charlotte Logeman, Natalie Crown, Anthony N T Ilersich, Mike Folinas, C Meghan McMurtry, Lucie M Bucci, Christine Shea, Vibhuti Shah, Heather Boon, Joel Katz, Lisa Dolovich, Anna Taddio
{"title":"Using the CARD system for university-based pop-up vaccination clinics: A two-stage hybrid effectiveness-implementation study.","authors":"Victoria Gudzak, Charlotte Logeman, Natalie Crown, Anthony N T Ilersich, Mike Folinas, C Meghan McMurtry, Lucie M Bucci, Christine Shea, Vibhuti Shah, Heather Boon, Joel Katz, Lisa Dolovich, Anna Taddio","doi":"10.1080/21645515.2025.2509484","DOIUrl":null,"url":null,"abstract":"<p><p>Mass vaccination clinics efficiently vaccinate large numbers of people. The CARD system (Comfort, Ask, Relax, Distract) is a vaccination delivery framework that can improve the experiences of vaccine recipients and providers. This two-stage hybrid effectiveness-implementation study implemented and sustained CARD in university-based vaccination clinics involving pharmacy student vaccinators. Stage 1 was a before-and-after study conducted across four COVID-19 vaccination clinics in November-December, 2022. Stage 2 was a single cohort study whereby CARD was sustained across four COVID-19/influenza vaccination clinics in November, 2023. In both stages, vaccine recipients rated experiences relative to last vaccination (<i>primary outcome</i>) and symptoms (pain, fear, dizziness) using surveys. Pharmacy student vaccinators completed attitudes and behaviors surveys; a subsample participated in focus groups. In Stage 1, more vaccine recipients in the after period (vs. before) reported a better vaccination experience relative to their last vaccination (64.0% vs 33.6%; <i>p</i> < .001; <i>n</i> = 181). Fear and pain were lower (1.1 vs. 1.7, <i>p</i> = .03; and 1.6 vs. 2.1, <i>p</i> = .02, respectively). In Stage 2, 57.4% (95% CI: 53.1%-61.6%; <i>n</i> = 542) of vaccine recipients reported a better experience. Across stages, pharmacy students had positive attitudes about acceptability, feasibility, and sustainability of CARD and reported high fidelity with CARD-recommended interventions. CARD is recommended for university-based vaccination clinics to improve vaccine recipient and provider experiences.</p>","PeriodicalId":49067,"journal":{"name":"Human Vaccines & Immunotherapeutics","volume":"21 1","pages":"2509484"},"PeriodicalIF":3.5000,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12333031/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Human Vaccines & Immunotherapeutics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/21645515.2025.2509484","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/8/7 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Mass vaccination clinics efficiently vaccinate large numbers of people. The CARD system (Comfort, Ask, Relax, Distract) is a vaccination delivery framework that can improve the experiences of vaccine recipients and providers. This two-stage hybrid effectiveness-implementation study implemented and sustained CARD in university-based vaccination clinics involving pharmacy student vaccinators. Stage 1 was a before-and-after study conducted across four COVID-19 vaccination clinics in November-December, 2022. Stage 2 was a single cohort study whereby CARD was sustained across four COVID-19/influenza vaccination clinics in November, 2023. In both stages, vaccine recipients rated experiences relative to last vaccination (primary outcome) and symptoms (pain, fear, dizziness) using surveys. Pharmacy student vaccinators completed attitudes and behaviors surveys; a subsample participated in focus groups. In Stage 1, more vaccine recipients in the after period (vs. before) reported a better vaccination experience relative to their last vaccination (64.0% vs 33.6%; p < .001; n = 181). Fear and pain were lower (1.1 vs. 1.7, p = .03; and 1.6 vs. 2.1, p = .02, respectively). In Stage 2, 57.4% (95% CI: 53.1%-61.6%; n = 542) of vaccine recipients reported a better experience. Across stages, pharmacy students had positive attitudes about acceptability, feasibility, and sustainability of CARD and reported high fidelity with CARD-recommended interventions. CARD is recommended for university-based vaccination clinics to improve vaccine recipient and provider experiences.

Abstract Image

Abstract Image

在大学弹出式疫苗接种诊所使用CARD系统:一项两阶段混合有效性实施研究。
大规模疫苗接种诊所有效地为大量人群接种疫苗。CARD系统(安慰、询问、放松、分散注意力)是一个疫苗接种提供框架,可以改善疫苗接受者和提供者的体验。这项两阶段混合有效性实施研究在大学疫苗接种诊所实施并维持了CARD,涉及药学专业学生接种员。第一阶段是2022年11月至12月在四个COVID-19疫苗接种诊所进行的前后研究。第二阶段是一项单队列研究,其中CARD于2023年11月在四个COVID-19/流感疫苗接种诊所持续进行。在这两个阶段,疫苗接种者通过调查评估与上次接种疫苗相关的经历(主要结果)和症状(疼痛、恐惧、头晕)。药学专业学生接种员完成态度和行为调查;一个子样本参加了焦点小组。在第一阶段,与上次接种疫苗相比,更多的疫苗接种者在接种后(与之前相比)报告了更好的疫苗接种体验(64.0%对33.6%;p n = 181)。恐惧和疼痛较低(1.1比1.7,p = .03;1.6 vs. 2.1, p =。02年,分别)。在第二阶段,57.4% (95% CI: 53.1%-61.6%;N = 542)的疫苗接种者报告了更好的体验。在各个阶段,药学学生对CARD的可接受性、可行性和可持续性持积极态度,并报告了CARD推荐的干预措施的高保真度。建议在大学疫苗接种诊所使用CARD,以改善疫苗接受者和提供者的经验。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Human Vaccines & Immunotherapeutics
Human Vaccines & Immunotherapeutics BIOTECHNOLOGY & APPLIED MICROBIOLOGY-IMMUNOLOGY
CiteScore
7.90
自引率
8.30%
发文量
489
审稿时长
3-6 weeks
期刊介绍: (formerly Human Vaccines; issn 1554-8619) Vaccine research and development is extending its reach beyond the prevention of bacterial or viral diseases. There are experimental vaccines for immunotherapeutic purposes and for applications outside of infectious diseases, in diverse fields such as cancer, autoimmunity, allergy, Alzheimer’s and addiction. Many of these vaccines and immunotherapeutics should become available in the next two decades, with consequent benefit for human health. Continued advancement in this field will benefit from a forum that can (A) help to promote interest by keeping investigators updated, and (B) enable an exchange of ideas regarding the latest progress in the many topics pertaining to vaccines and immunotherapeutics. Human Vaccines & Immunotherapeutics provides such a forum. It is published monthly in a format that is accessible to a wide international audience in the academic, industrial and public sectors.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信